...
首页> 外文期刊>Journal of Medicinal Chemistry >Novel selective PDE4 inhibitors. 3. In vivo antiinflammatory activity of a new series of N-substituted cis-tetra- and cis-hexahydrophthalazinones.
【24h】

Novel selective PDE4 inhibitors. 3. In vivo antiinflammatory activity of a new series of N-substituted cis-tetra- and cis-hexahydrophthalazinones.

机译:新型选择性PDE4抑制剂。 3.一系列新的N-取代的顺-四-和顺-六氢邻苯二氮酮的体内抗炎活性。

获取原文
获取原文并翻译 | 示例
           

摘要

The synthesis and biological activities of a series of N-substituted cis-4a,5,6,7,8,8a-hexa- and cis-4a,5,8,8a-tetrahydro-2H-phthalazin-1-ones are described. It was found that compounds bearing a cycloalkyl group at the 2-position exhibit the highest PDE4 inhibitory activities (pIC(50) = 8.6-9.4). The N-cycloheptyl- and N-adamantanyltetrahydrophthalazinones (7h, 8, 10, 11) show high in vivo antiinflammatory activities after oral application. Additionally, some phthalazinones were found to exhibit potent suppression of LPS-induced TNFalpha release and show moderate potency against fMLP-stimulated production of ROS.
机译:描述了一系列N-取代的顺式4a,5,6,7,8,8a-六-和顺式4a,5,8,8a-四氢-2H-酞嗪-1-酮的合成和生物学活性。发现在2-位带有环烷基的化合物表现出最高的PDE4抑制活性(pIC(50)= 8.6-9.4)。 N-环庚基-和N-金刚烷基四氢邻苯二氮酮(7h,8、10、11)在口服后显示出很高的体内抗炎活性。另外,发现一些邻苯二氮酮显示出对LPS诱导的TNFα释放的有效抑制作用,并且对fMLP刺激的ROS产生适度的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号